26 Jun 2013
A study published in JAMA Internal Medicine has reported that hormone replacement therapy taken by postmenopausal women aged 50-55 is not linked to risk of cognitive problems.
New Awards Committee Chair
29 Jan 2025
Society for Endocrinology endorses landmark guidelines for childhood pituitary tumour care
29 Jan 2025
Announcing the Winners of the SfE Emerging Researcher Lectures 2025
23 Jan 2025
Congratulations to the awardees of our third round of 2024 grants
22 Jan 2025